BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 26717917)

  • 1. Diagnostic Values of Carcinoembryonic Antigen, Cancer Antigen 15-3 and Cancer Antigen 125 Levels in Nipple Discharge.
    Zhao S; Gai X; Wang Y; Liang W; Gao H; Zhang K; Wang H; Liu Y; Wang J; Ma R
    Chin J Physiol; 2015 Dec; 58(6):385-92. PubMed ID: 26717917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.
    Zhao S; Mei Y; Wang J; Zhang K; Ma R
    PLoS One; 2016; 11(6):e0157639. PubMed ID: 27327081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.
    Wang G; Qin Y; Zhang J; Zhao J; Liang Y; Zhang Z; Qin M; Sun Y
    Int J Mol Sci; 2014 May; 15(6):9546-65. PubMed ID: 24879526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of Nipple Discharge: Value of Magnetic Resonance Imaging and Ultrasonography in Comparison with Ductoscopy.
    Yılmaz R; Bender Ö; Çelik Yabul F; Dursun M; Tunacı M; Acunas G
    Balkan Med J; 2017 Apr; 34(2):119-126. PubMed ID: 28418338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a panel of tumor markers (carcinoembryonic antigen, cancer antigen 125, carbohydrate antigen 15-3, and cytokeratin 19 fragments) in pleural fluid for the differential diagnosis of benign and malignant effusions.
    Porcel JM; Vives M; Esquerda A; Salud A; Pérez B; Rodríguez-Panadero F
    Chest; 2004 Dec; 126(6):1757-63. PubMed ID: 15596670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nipple aspirate fluid collection, related factors and relationship between carcinoembryonic antigen in nipple aspirate fluid and breast diseases in women in Harbin, PRC.
    Zhao YS; Pang D; Wang F; Xue YW; Gao DN; Li H; Li K; Wang BY; Wang D; Li HY
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):732-8. PubMed ID: 19273481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of dot-immunobinding assay for carcinoembryonic antigen determination in nipple discharge as an adjunct in the diagnosis of early breast cancer. Research Group for Carcinoembryonic Antigen in Nipple Discharge.
    Mori T; Inaji H; Higashiyama M; Yayoi E; Izuo M; Ueno E; Enomoto K; Kasumi F; Sakamoto G; Tominaga T
    Jpn J Clin Oncol; 1989 Dec; 19(4):373-9. PubMed ID: 2691732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraductal aspiration cytology and galactography for nipple discharge.
    Baitchev G; Gortchev G; Todorova A; Dikov D; Stancheva N; Daskalova I
    Int Surg; 2003; 88(2):83-6. PubMed ID: 12872900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammary ductoscopy for the evaluation of nipple discharge and comparison with standard diagnostic techniques.
    Grunwald S; Bojahr B; Schwesinger G; Schimming A; Kohler G; Schulz K; Ohlinger R
    J Minim Invasive Gynecol; 2006; 13(5):418-23. PubMed ID: 16962525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carcinoembryonic antigen estimation in nipple discharge as an adjunctive tool in the diagnosis of early breast cancer.
    Inaji H; Yayoi E; Maeura Y; Matsuura N; Tominaga S; Koyama H; Takatsuka Y; Mori T
    Cancer; 1987 Dec; 60(12):3008-13. PubMed ID: 3677024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nipple fluid carcinoembryonic antigen and prostate-specific antigen in cancer-bearing and tumor-free breasts.
    Zhao Y; Verselis SJ; Klar N; Sadowsky NL; Kaelin CM; Smith B; Foretova L; Li FP
    J Clin Oncol; 2001 Mar; 19(5):1462-7. PubMed ID: 11230492
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CA-15.3 assay in effusions: comparison with carcinoembryonic antigen and CA-125 assay and cytologic diagnosis.
    Pinto MM
    Acta Cytol; 1996; 40(3):437-42. PubMed ID: 8669175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nipple discharge disorders: current diagnostic management and the role of fiber-ductoscopy.
    Okazaki A; Hirata K; Okazaki M; Svane G; Azavedo E
    Eur Radiol; 1999; 9(4):583-90. PubMed ID: 10354867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical usefulness of carcinoembryonic antigen measurement in nipple discharge as an adjunctive tool for diagnosis of breast cancer].
    Nishiguchi T; Hishimoto T; Funahashi S; Takatsuka Y; Kawahara T
    Rinsho Byori; 1992 Jan; 40(1):67-72. PubMed ID: 1545528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactography is not an obsolete investigation in the evaluation of pathological nipple discharge.
    Istomin A; Masarwah A; Pitkänen M; Joukainen S; Sutela A; Vanninen R; Sudah M
    PLoS One; 2018; 13(10):e0204326. PubMed ID: 30296280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galactography and exfoliative cytology in women with abnormal nipple discharge.
    Dinkel HP; Gassel AM; Müller T; Lourens S; Rominger M; Tschammler A
    Obstet Gynecol; 2001 Apr; 97(4):625-9. PubMed ID: 11275040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The "Trunk sign": A novel X-ray sign in galactography of patients with nipple discharge suggesting malignancy.
    Wu T; Zhang K; Wang Y; Ma R
    Medicine (Baltimore); 2023 Aug; 102(32):e34589. PubMed ID: 37565883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Early detection of non-palpable (T0) breast cancer: the diagnostic procedure for pathological discharge from the nipple].
    Yayoi E; Furukawa J; Sekimoto M; Tateishi H; Kinuta M; Maruyama H; Okamura J
    Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():133-9. PubMed ID: 8037475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers.
    Dolscheid-Pommerich RC; Keyver-Paik M; Hecking T; Kuhn W; Hartmann G; Stoffel-Wagner B; Holdenrieder S
    Tumour Biol; 2017 Oct; 39(10):1010428317730246. PubMed ID: 29034816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.